Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evolution of Tissue Perfusion and Venous Congestion Markers in Fluid-Responsive Septic Shock Patients: Evaluating the Benefit-Risk Balance of Fluid Resuscitation

NCT06958809 is registered in ClinicalTrials.gov with Hospital Ambroise Paré Paris as lead sponsor.

NCT NCT06958809
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06958809 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evolution of Tissue Perfusion and Venous Congestion Markers in Fluid-Responsive Septic Shock Patients: Evaluating the Benefit-Risk Balance of Fluid Resuscitation
Lead sponsor
Hospital Ambroise Paré Paris
Phase
Observational
Overall status
Not yet recruiting
Start date
February 1, 2026
Completion date
August 1, 2027
Enrollment
200 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

congestion, venous, fluid resuscitation, septic shock